Search Results - "Edelstein, Jasmine N."

Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population by Yang, Qi, Jacobs, Timothy M, McCallen, Justin D, Moore, Dominic T, Huckaby, Justin T, Edelstein, Jasmine N, Lai, Samuel K

“…Circulating antibodies (Ab) that specifically bind polyethylene glycol (PEG), a biocompatible polymer routinely used in protein and nanoparticle therapeutics,…”
Get full text

AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines by Zhang, Liyang, Zuris, John A., Viswanathan, Ramya, Edelstein, Jasmine N., Turk, Rolf, Thommandru, Bernice, Rube, H. Tomas, Glenn, Steve E., Collingwood, Michael A., Bode, Nicole M., Beaudoin, Sarah F., Lele, Swarali, Scott, Sean N., Wasko, Kevin M., Sexton, Steven, Borges, Christopher M., Schubert, Mollie S., Kurgan, Gavin L., McNeill, Matthew S., Fernandez, Cecilia A., Myer, Vic E., Morgan, Richard A., Behlke, Mark A., Vakulskas, Christopher A.

“…Though AsCas12a fills a crucial gap in the current genome editing toolbox, it exhibits relatively poor editing efficiency, restricting its overall utility…”
Get full text

Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines by Zhang, Liyang, Zuris, John A., Viswanathan, Ramya, Edelstein, Jasmine N., Turk, Rolf, Thommandru, Bernice, Rube, H. Tomas, Glenn, Steve E., Collingwood, Michael A., Bode, Nicole M., Beaudoin, Sarah F., Lele, Swarali, Scott, Sean N., Wasko, Kevin M., Sexton, Steven, Borges, Christopher M., Schubert, Mollie S., Kurgan, Gavin L., McNeill, Matthew S., Fernandez, Cecilia A., Myer, Vic E., Morgan, Richard A., Behlke, Mark A., Vakulskas, Christopher A.

Get full text

Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing by Hill, Tyler F, Narvekar, Parnal, Asher, Gregory D, Edelstein, Jasmine N, Camp, Nathan D, Grimm, Annaiz, Thomas, Kerri R, Leiken, Michael D, Molloy, Katherine M, Cook, Peter J, Arlauckas, Sean P, Morgan, Richard A, Tasian, Sarah K, Rawlings, David J, James, Richard G

“…Bispecific antibodies are an important tool for the management and treatment of acute leukemias. As a next step toward clinical translation of engineered…”
Get more information

409 Development of ex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics by Edelstein, Jasmine N, Hill, Tyler F, Leiken, Michael D, Molloy, Katherine M, Adekanye, Glory, Bullock, Caroline, Lazorchak, Adam S, Aryee, Ken-Edwin, Rawlings, David J, James, Richard G, Morgan, Richard A, Arlauckas, Sean P

“…BackgroundBispecific T Cell Engagers (BiTEs), consisting of an anti-CD3 scFv fused to an anti-tumor antigen scFv, are highly effective in the treatment of…”
Get full text

409 Development ofex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics by Edelstein, Jasmine N, Hill, Tyler F, Leiken, Michael D, Molloy, Katherine M, Adekanye, Glory, Bullock, Caroline, Lazorchak, Adam S, Ken-Edwin Aryee, Rawlings, David J, James, Richard G, Morgan, Richard A, Arlauckas, Sean P

“…BackgroundBispecific T Cell Engagers (BiTEs), consisting of an anti-CD3 scFv fused to an anti-tumor antigen scFv, are highly effective in the treatment of…”
Get full text